Literature DB >> 11839150

Maintaining low HIV type 1 env genetic diversity among injection drug users infected with a B/C recombinant and CRF01_AE HIV type 1 in southern China.

Xiao-Fang Yu1, Wei Liu, Jie Chen, Wei Kong, Bindong Liu, Qiuying Zhu, Fuxiong Liang, Francine McCutchan, Sucheep Piyasirisilp, Shenghan Lai.   

Abstract

HIV-1 outbreaks in Guangxi Province, southern China were initiated from two separate border cities in 1996 and 1997. Drug users in Pingxiang City, which borders Vietnam, were infected with CRF01_AE HIV-1, and drug users in Baise City, which borders Yunan Province, were infected with a novel B/C recombinant HIV-1. Since 1997, HIV-1 has been rapidly spreading in Guangxi, including its capital city Nanning. Survey data indicated that HIV-1 prevalence among IDUs in new outbreak regions increased 8 to 42% within 1 year. The B/C recombinants obtained from five separate regions in Guangxi, which span a 4-year time frame, were remarkable for their low intersubject env V3 diversity, less than 0.2%. Similarly, the CRF01_AE from IDUs over a 3-year time frame had low intersubject env V3 diversity of less than 1.6%. Different patterns of sequence variations in the V3 and V4 regions were observed for the B/C recombinant and the CRF01_AE HIV1. The rapid spreading of homogeneous HIV-1 strains in Guangxi may have important implications for HIV transmission as well as vaccine development and evaluation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839150     DOI: 10.1089/08892220252779719

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  Short communication: phylogenetic characterization of HIV type 1 CRF01_AE V3 envelope sequences in pregnant women in Northern Vietnam.

Authors:  Rozina Caridha; Tran Thi Thanh Ha; Simani Gaseitsiwe; Pham Viet Hung; Nguyen Mai Anh; Nguyen Huy Bao; Dinh Duy Khang; Nguyen Tran Hien; Phung Dac Cam; Francesca Chiodi; Anneka Ehrnst
Journal:  AIDS Res Hum Retroviruses       Date:  2011-11-11       Impact factor: 2.205

2.  HIV-1 transmission among injection drug users leads to novel recombinants circulating in southern China.

Authors:  Ke Zhao; Juan Du; Wenwen Zheng; Xiao-Fang Yu
Journal:  AIDS Res Hum Retroviruses       Date:  2014-10       Impact factor: 2.205

3.  Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia.

Authors:  Kok Keng Tee; Oliver G Pybus; Xiao-Jie Li; Xiaoxu Han; Hong Shang; Adeeba Kamarulzaman; Yutaka Takebe
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

4.  Prevalence of HIV infection and predictors for syphilis infection among female sex workers in southern China.

Authors:  Fan Lu; Yujiang Jia; Xinhua Sun; Lan Wang; Wei Liu; Yan Xiao; Gang Zeng; Chunmei Li; Jianbo Liu; Holly Cassell; Huey T Chen; Sten H Vermund
Journal:  Southeast Asian J Trop Med Public Health       Date:  2009-03       Impact factor: 0.267

5.  Analysis of HIV Correlated Factors in Chinese and Vietnamese Female Sex Workers in Hekou, Yunnan Province, a Chinese Border Region.

Authors:  Junjie Wang; Guowei Ding; Zhibin Zhu; Chunlian Zhou; Ning Wang
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

Review 6.  Host genomic influences on HIV/AIDS.

Authors:  Stephen J O'Brien; Sher L Hendrickson
Journal:  Genome Biol       Date:  2013-01-31       Impact factor: 13.583

7.  HIV-1 diversity, drug-resistant mutations, and viral evolution among high-risk individuals in phase II HIV vaccine trial sites in southern China.

Authors:  Haiyan Qi; Ke Zhao; Fei Xu; Xuzhao Zhang; Zhiyong Zhang; Li Yang; Chunling Li; Xu Liang; Weigui Guo; Shihai Chen; Zhihao Liu; Wenyan Zhang; Xiao-Fang Yu
Journal:  PLoS One       Date:  2013-07-15       Impact factor: 3.240

8.  HIV-1 diversity and drug-resistant mutations in infected individuals in Changchun, China.

Authors:  Ming Yan; Ke Zhao; Juan Du; Linzhang Li; Donglin Wu; Shengming Xu; Xiangchao Zeng; Guanjun Wang; Xiao-Fang Yu
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.